Richard Czerniak

687 total citations
18 papers, 529 citations indexed

About

Richard Czerniak is a scholar working on Endocrinology, Diabetes and Metabolism, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Richard Czerniak has authored 18 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Richard Czerniak's work include Gastroesophageal reflux and treatments (3 papers), Diabetes Treatment and Management (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Richard Czerniak is often cited by papers focused on Gastroesophageal reflux and treatments (3 papers), Diabetes Treatment and Management (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Richard Czerniak collaborates with scholars based in United States, Japan and Switzerland. Richard Czerniak's co-authors include Harold W. Moore, Emerich S. Fiala, C. Clifford Conaway, André Castonguay, Abraham Rivenson, Ahmed M. Hamdan, Ock Soon Sohn, Hitomi Yamasaki, Mitsuhiro Nishihara and Thomas Block and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and The American Journal of Gastroenterology.

In The Last Decade

Richard Czerniak

16 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Czerniak United States 9 189 185 85 55 54 18 529
KAZUYUKI NAKAGAWA Japan 19 320 1.7× 339 1.8× 27 0.3× 70 1.3× 83 1.5× 68 815
Jing Hao China 17 365 1.9× 97 0.5× 46 0.5× 34 0.6× 46 0.9× 41 867
Huagang Liu China 16 277 1.5× 123 0.7× 16 0.2× 32 0.6× 60 1.1× 42 661
Danylo Kaminskyy Ukraine 23 398 2.1× 1.1k 5.9× 73 0.9× 18 0.3× 121 2.2× 52 1.5k
Atul Khandwala United States 17 261 1.4× 243 1.3× 13 0.2× 102 1.9× 97 1.8× 47 892
Lei Lei China 16 348 1.8× 46 0.2× 21 0.2× 56 1.0× 81 1.5× 49 671
Chun‐Hsiung Wu Taiwan 10 157 0.8× 72 0.4× 104 1.2× 25 0.5× 71 1.3× 20 435
Michael H. Buonarati United States 15 224 1.2× 54 0.3× 36 0.4× 92 1.7× 52 1.0× 25 581
Appavu Chandrasekaran United States 15 178 0.9× 59 0.3× 9 0.1× 92 1.7× 54 1.0× 43 595
Zbyněk Svoboda Czechia 14 123 0.7× 51 0.3× 18 0.2× 161 2.9× 100 1.9× 27 580

Countries citing papers authored by Richard Czerniak

Since Specialization
Citations

This map shows the geographic impact of Richard Czerniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Czerniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Czerniak more than expected).

Fields of papers citing papers by Richard Czerniak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Czerniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Czerniak. The network helps show where Richard Czerniak may publish in the future.

Co-authorship network of co-authors of Richard Czerniak

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Czerniak. A scholar is included among the top collaborators of Richard Czerniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Czerniak. Richard Czerniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Peng, Xuejun, Georgeanna J. Klingensmith, Daniel S. Hsia, et al.. (2025). A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus. Diabetes Therapy. 16(5). 865–883.
2.
3.
Czerniak, Richard, et al.. (2022). The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK‐954). The Journal of Clinical Pharmacology. 62(8). 1006–1017.
4.
Chowdhury, Swapan K., et al.. (2022). Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist. European Journal of Drug Metabolism and Pharmacokinetics. 47(3). 371–386. 2 indexed citations
5.
6.
Maringwa, John, et al.. (2020). Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure. Clinical Pharmacology & Therapeutics. 109(6). 1583–1592. 15 indexed citations
7.
Czerniak, Richard, Yinzhong Chen, Chris Barnes, et al.. (2019). Mo1581 – Evaluation of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of Tak–954 in a Randomized, Placebo-Controlled Phase 1 Study. Gastroenterology. 156(6). S–789. 3 indexed citations
8.
Nishihara, Mitsuhiro, Hitomi Yamasaki, Richard Czerniak, & Helen Jenkins. (2018). In Vitro Assessment of Potential for CYP-Inhibition-Based Drug–Drug Interaction Between Vonoprazan and Clopidogrel. European Journal of Drug Metabolism and Pharmacokinetics. 44(2). 217–227. 15 indexed citations
9.
Naik, Himanshu, Richard Czerniak, & Majid Vakilynejad. (2015). Application of pharmacometric approaches to evaluate effect of weight and renal function on pharmacokinetics of alogliptin. British Journal of Clinical Pharmacology. 81(4). 700–712. 2 indexed citations
10.
Czerniak, Richard, Michael Kukulka, Jing Wu, & Ping Qiu. (2014). Effects of peginesatide injection on QTc interval in healthy adults. Clinical Pharmacology in Drug Development. 3(6). 449–455. 3 indexed citations
11.
Czerniak, Richard, Majid Vakily, & Jingtao Wu. (2008). TAK-390MR, a Novel Dual Delayed Release Formulation of a PPI, Is Bioequivalent When Administered as Granules Sprinkled Over Applesauce or as an Intact Capsule. The American Journal of Gastroenterology. 103. S4–S5. 6 indexed citations
12.
Czerniak, Richard. (2001). Gender-Based Differences in Pharmacokinetics in Laboratory Animal Models. International Journal of Toxicology. 20(3). 161–163. 91 indexed citations
13.
Diana, Guy D., Patrick J. Rudewicz, Daniel C. Pevear, et al.. (1995). Picornavirus Inhibitors: Trifluoromethyl Substitution Provides a Global Protective Effect against Hepatic Metabolism. Journal of Medicinal Chemistry. 38(8). 1355–1371. 83 indexed citations
14.
Fiala, Emerich S., Richard Czerniak, André Castonguay, C. Clifford Conaway, & Abraham Rivenson. (1987). Assay of 1-nitropropane, 2-nitropropane, 1-azoxypropane and 2-azoxypropane for carcinogenicity by gavage in Sprague—Dawley rats. Carcinogenesis. 8(12). 1947–1949. 59 indexed citations
15.
Fiala, Emerich S., et al.. (1987). Differential effects of 4-iodopyrazole and 3-methylpyrazole on the metabolic activation of methylazoxymethanol to a DNA methylating species by rat liver and rat colon mucosa in vivo. Journal of Cancer Research and Clinical Oncology. 113(2). 145–150. 20 indexed citations
16.
Czerniak, Richard, et al.. (1986). Natural quinones as quinonemethide precursors--ideas in rational drug design.. PubMed. 12(6-7). 475–94. 18 indexed citations
17.
Moore, Harold W. & Richard Czerniak. (1982). ChemInform Abstract: NATURALLY OCCURRING QUINONES AS POTENTIAL BIOREDUCTIVE ALKYLATING AGENTS. Chemischer Informationsdienst. 13(2). 5 indexed citations
18.
Moore, Harold W. & Richard Czerniak. (1981). Naturally occurring quinones as potential bioreductive alkylating agents. Medicinal Research Reviews. 1(3). 249–280. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by KAZUYUKI NAKAGAWA Breakdown of academic impact, for papers by Jing Hao Breakdown of academic impact, for papers by Huagang Liu Breakdown of academic impact, for papers by Danylo Kaminskyy Breakdown of academic impact, for papers by Atul Khandwala Breakdown of academic impact, for papers by Lei Lei Breakdown of academic impact, for papers by Chun‐Hsiung Wu Breakdown of academic impact, for papers by Michael H. Buonarati Breakdown of academic impact, for papers by Appavu Chandrasekaran Breakdown of academic impact, for papers by Zbyněk Svoboda
Rankless by CCL
2026